News & Updates

Edoxaban prevents thromboembolism in children with cardiac disease
Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023

Edoxaban may be used as an alternative treatment for thromboembolism (TE) prevention in children with cardiac disease showing low rates of clinically relevant bleeding and TE, suggests a study. Some of its advantages include once-daily dosing and infrequent monitoring requirement.

Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022 byJairia Dela Cruz

Bromocriptine quick release, a medication used for Parkinson’s disease and type 2 diabetes (T2D), appears to confer cardiovascular benefits such as lower blood pressure (BP) and reduced aortic stiffness in teenagers with type 1 diabetes (T1D), according to data from the BCQR-T1D study.

Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022